Submitted by Anonymous (not verified) on 22 July 2025 - 16:12
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of authorisation: 28/04/2014, Revision: 22, Status: Authorised
Source: